Altavo

Altavo is a medical device startup headquartered in Dresden, Germany. Established in 2021, the company's slogan, "The Artificial Voice Company - giving voiceless people an individual, natural sounding voice," reflects their core mission of utilizing machine learning and cutting-edge sensor technology to enhance the lives of individuals who have lost their voice. Their initial focus is on aiding patients who have undergone laryngectomy due to tumor surgery, with potential applications in speech rehabilitation and non-medical sectors. The diverse team, with expertise in areas such as medical device development, artificial intelligence, and linguistics, is united in its commitment to transforming advanced technologies into products that enhance the quality of life for patients. Their most recent milestone was a €5.00M Series A investment secured on 20th February 2024, with support from prominent investors, including High-Tech Gründerfonds, Occident, TGFS - Technologiegründerfonds Sachsen, Novalis Biotech, bm-t beteiligungsmanagement thüringen GmbH, TUDAG, and Saxonia Systems Holding GmbH. This funding not only validates Altavo's potential but also provides essential capital to further their innovative initiatives in the Health Care and Manufacturing industries. As Altavo continues to progress, their dedication to leveraging technology to support individuals without a voice is likely to drive significant impact and success.